GMP Violations at Drug Substance Makers Prompt Series of New Voluntary Recalls of Generics; Stable Supplies Disrupted

A number of generic drug makers have initiated voluntary product recalls due to defects in production control identified by the Pharmaceuticals and Medical Devices Agency (PMDA) through its GMP compliance inspections. As of January 10, Nichi-Iko Pharmaceutical, followed by Teva...read more